Our strategic objectives

In order to obtain innovative medicines that offer solutions to a variety of disorders, Almirall maintains three basic strategic premises:

• Foster our research and development (R&D) as growth driving.

• Strengthen our international presence.

• Maintaining leadership in the Spanish market.

With the aim of aiding the fight against disease our research and development policy focuses on discovering innovative drugs, both through our own research projects and with other companies and research centres.

We work to strengthen our position in countries where we already have affiliates, Austria, Belgium, France, Germany, Italy, Mexico, Nordic countries, Poland, Portugal, the United Kingdom-Ireland and Switzerland, and to analyse investment opportunities in other markets, in addition to forming strategic alliances with other international pharmaceutical companies.

Our objective is to consolidate ourselves as a pan-European benchmark pharmaceutical company. Almirall's products are currently present in over 70 countries.

In addition, the proven efficacy of our products, together with the dedication and professionalism of our workforce, has made us leaders in the Spanish market, a position we intend to reinforce significantly. Our aim is to maintain our position as leaders of the pharmaceutical sector in Spain.